242 related articles for article (PubMed ID: 29625790)
1. Transfusion-associated hazards: A revisit of their presentation.
Garraud O; Sut C; Haddad A; Tariket S; Aloui C; Laradi S; Hamzeh-Cognasse H; Bourlet T; Zeni F; Aubron C; Ozier Y; Laperche S; Peyrard T; Buffet P; Guyotat D; Tavernier E; Cognasse F; Pozzetto B; Andreu G
Transfus Clin Biol; 2018 May; 25(2):118-135. PubMed ID: 29625790
[TBL] [Abstract][Full Text] [Related]
2. Serious Hazards of Transfusion (SHOT) haemovigilance and progress is improving transfusion safety.
Bolton-Maggs PH; Cohen H
Br J Haematol; 2013 Nov; 163(3):303-14. PubMed ID: 24032719
[TBL] [Abstract][Full Text] [Related]
3. The International Haemovigilance Network Database for the Surveillance of Adverse Reactions and Events in Donors and Recipients of Blood Components: technical issues and results.
Politis C; Wiersum JC; Richardson C; Robillard P; Jorgensen J; Renaudier P; Faber JC; Wood EM
Vox Sang; 2016 Nov; 111(4):409-417. PubMed ID: 27658188
[TBL] [Abstract][Full Text] [Related]
4. [Réactions transfusionnelles].
Chiaroni J
Rev Prat; 2018 Nov; 68(9):1029-1033. PubMed ID: 30869366
[TBL] [Abstract][Full Text] [Related]
5. [Hemovigilance: State 2007-2013 Tunis].
Mahjoub S; Baccouche H; Raissi A; Ben Hamed L; Ben Romdhane N
Transfus Clin Biol; 2017 Feb; 24(1):15-22. PubMed ID: 27955922
[TBL] [Abstract][Full Text] [Related]
6. How to mitigate the risk of inducing transfusion-associated adverse reactions.
Garraud O; Cognasse F; Laradi S; Hamzeh-Cognasse H; Peyrard T; Tissot JD; Fontana S
Transfus Clin Biol; 2018 Nov; 25(4):262-268. PubMed ID: 30139570
[TBL] [Abstract][Full Text] [Related]
7. The French haemovigilance system.
Noel L; Debeir J; Cosson A
Vox Sang; 1998; 74 Suppl 2():441-5. PubMed ID: 9704479
[TBL] [Abstract][Full Text] [Related]
8. [Transfusion reactions in patients: haemovigilance reports to the Dutch National Haemovigilance Office in 2003].
Wiersum-Osselton JC; Schipperus MR
Ned Tijdschr Geneeskd; 2005 Nov; 149(47):2622-7. PubMed ID: 16355575
[TBL] [Abstract][Full Text] [Related]
9. The French haemovigilance system.
Debeir J; Noel L; Aullen J; Frette C; Sari F; Mai MP; Cosson A
Vox Sang; 1999; 77(2):77-81. PubMed ID: 10516551
[TBL] [Abstract][Full Text] [Related]
10. Eight years with haemovigilance in Norway. What have we learnt?
Steinsvåg CT; Espinosa A; Flesland Ø
Transfus Apher Sci; 2013 Dec; 49(3):548-52. PubMed ID: 24157220
[TBL] [Abstract][Full Text] [Related]
11. Review of haemovigilance at the Rabat Regional Blood Transfusion Centre in Morocco (2017-2021).
Lemssahli I; Benajiba M; Belmekki A
Pan Afr Med J; 2024; 47():60. PubMed ID: 38646139
[TBL] [Abstract][Full Text] [Related]
12. Haemovigilance: an effective tool for improving transfusion practice.
de Vries RR; Faber JC; Strengers PF;
Vox Sang; 2011 Jan; 100(1):60-7. PubMed ID: 21175656
[TBL] [Abstract][Full Text] [Related]
13. The Incidence Rate of Acute Transfusion Reactions in Thalassemia Patients Referred to the Shiraz Thalassemia Centre, Shiraz, Iran, Before and After the Establishment of the Hemovigilance System.
Kasraian L; Karimi MH
Hemoglobin; 2015; 39(4):274-80. PubMed ID: 26036919
[TBL] [Abstract][Full Text] [Related]
14. International haemovigilance: what have we learned and what do we need to do next?
Wood EM; Ang AL; Bisht A; Bolton-Maggs PH; Bokhorst AG; Flesland O; Land K; Wiersum-Osselton JC; Schipperus MR; Tiberghien P; Whitaker BI
Transfus Med; 2019 Aug; 29(4):221-230. PubMed ID: 30729612
[TBL] [Abstract][Full Text] [Related]
15. Direct costs of transfusion reactions - an expert judgement approach.
Janssen MP; van Tilborgh AJW; de Vooght KMK; Bokhorst AG; Wiersum-Osselton JC
Vox Sang; 2018 Feb; 113(2):143-151. PubMed ID: 29124766
[TBL] [Abstract][Full Text] [Related]
16. Significance of mandating a dedicated hemovigilance nurse and objectification of 'imputability' levels. Experience from a hospital-based blood centre in India.
Dhiman Y; Raturi M; Kala M; Kusum A
Transfus Clin Biol; 2023 Feb; 30(1):96-102. PubMed ID: 36162622
[TBL] [Abstract][Full Text] [Related]
17. Transfusion-related adverse reactions: Data from the National Healthcare Safety Network Hemovigilance Module - United States, 2013-2018.
Kracalik I; Mowla S; Basavaraju SV; Sapiano MRP
Transfusion; 2021 May; 61(5):1424-1434. PubMed ID: 33880771
[TBL] [Abstract][Full Text] [Related]
18. Development and implementation of a hemovigilance program at a university veterinary teaching hospital.
Haines JM; Ngwenyama TR; Martin LG; Wardrop KJ
J Vet Emerg Crit Care (San Antonio); 2022 May; 32(3):315-321. PubMed ID: 35001463
[TBL] [Abstract][Full Text] [Related]
19. Study of acute transfusion reactions in a teaching hospital of Sikkim: A hemovigilance initiative.
Sharma DK; Datta S; Gupta A
Indian J Pharmacol; 2015; 47(4):370-4. PubMed ID: 26285707
[TBL] [Abstract][Full Text] [Related]
20. International validation of harmonized definitions for complications of blood donations.
Land KJ; Townsend M; Goldman M; Whitaker BI; Perez GE; Wiersum-Osselton JC
Transfusion; 2018 Nov; 58(11):2589-2595. PubMed ID: 30294786
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
